3Montalescot G,Ankri A,Chadefanx-vekemans B,et al.Plasma homocysteine and the extent of atherosclerosis in patients with coronary disease.Int J Cardiol.1997,60:295.
4Mayer EL,Jacobsen DW,Robinson K,et al.Homocysteine and coronary atherosclerosis.JAM Coll Cardiol.1996,23(3):517.
6McCully KS.Vascular pathology of homocysteinemia:implications for the pathogenesis of arteriosclerosis.Am J Pathol,1969,56:111-128.
7Sacco RL,Roberts JK,Jacobs BS.Homocysteine as a risk factor for ischemic stroke:an epidemiological story in evolution.Neuroepidemiology,1998,17:167-173.
8Houston PE,Rana S,Sekhsaria S,et al.Homocysteine in sickle cell disease:relationship to stroke.Am J Med,1997,103:192-196.
9Wong KS,Huang YN,Gao S,et al.Intracranial stenosis in Chinese patients with acute stroke.Neurology,1998,50:812-813.
10Refsum H,Ueland PM.Clinical significance of pharmacological modulation of homocysteine metabolism.TIPS,1990,11:411-416.
5Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease[J]. Kidney Int, 2011, 79(12) : 1370-1378.
6He J,Reilly M,Yang W,et al. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study)[J]. Am J Cardiol,2012,110(12):1735-1741.
7H erzog CA, Asinger RW, Berger AK, et al. Cardiovascu- lar disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDI-GO) [J]. Kidney Int,2011,80(6) :572-586.
